You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

danvatirsen

Showing 1 - 5 of 5
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

AML/MDS, Acute Myeloid Leukemia, MDS Trial (Danvatirsen, Danvatirsen + Venetoclax)

Not yet recruiting
  • AML/MDS
  • +2 more
  • Danvatirsen
  • Danvatirsen + Venetoclax
  • (no location specified)
Aug 14, 2023

HNSCC Trial (Danvatirsen, Pembrolizumab)

Not yet recruiting
  • HNSCC
  • (no location specified)
Apr 3, 2023

Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Carcinoma Trial in Houston

Active, not recruiting
  • Advanced Colorectal Carcinoma
  • +24 more
  • Danvatirsen
  • Durvalumab
  • Houston, Texas
    M D Anderson Cancer Center
Oct 20, 2022

Resectable, Early-stage, NSCLC Trial in Worldwide (Durvalumab, Oleclumab, Monalizumab)

Completed
Has Results
  • Resectable
  • +2 more
  • La Jolla, California
  • +17 more
Feb 23, 2022

Metastatic NSCLC (NSCLC) Trial in Worldwide (Durvalumab, Danvatirsen, Oleclumab)

Active, not recruiting
  • Metastatic Non-Small Cell Lung Cancer (NSCLC)
  • Iowa City, Iowa
  • +45 more
Jan 13, 2023